We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+19.07%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$1.44B
AUM Growth
+$344M
Cap. Flow
+$171M
Cap. Flow %
11.87%
Top 10 Hldgs %
38.33%
Holding
267
New
32
Increased
87
Reduced
92
Closed
18

Sector Composition

Rank Sector Weight
1 Technology 11.45%
2 Healthcare 7.84%
3 Industrials 4.96%
4 Financials 4.44%
5 Consumer Discretionary 3.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BP icon
201
BP
BP
$114B
$296K 0.02%
12,696
+253
+2% +$6.07K
PTON icon
202
Peloton Interactive
PTON
$2.71B
$293K 0.02%
+5,065
New +$210K
FBIN icon
203
Fortune Brands Innovations
FBIN
$5.75B
$291K 0.02%
+5,316
New +$247K
ROK icon
204
Rockwell Automation
ROK
$52.3B
$278K 0.02%
+1,304
New +$252K
PPL
205
PPL Corp
PPL
$26.7B
$274K 0.02%
+10,600
New +$276K
EXC icon
206
Exelon
EXC
$47B
$269K 0.02%
+10,376
New +$275K
GPC icon
207
Genuine Parts
GPC
$17.3B
$268K 0.02%
3,084
LMT icon
208
Lockheed Martin
LMT
$132B
$266K 0.02%
730
AMT icon
209
American Tower
AMT
$80B
$263K 0.02%
1,017
CI icon
210
Cigna
CI
$74.8B
$263K 0.02%
1,401
SCHB icon
211
Schwab US Broad Market ETF
SCHB
$42.7B
$263K 0.02%
21,444
+6
+0% +$69
SHM icon
212
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.46B
$263K 0.02%
5,270
QAI icon
213
NYLI Hedge Multi-Strategy Tracker ETF
QAI
$1.01B
$257K 0.02%
8,483
-8,077
-49% -$239K
VEU icon
214
Vanguard FTSE All-World ex-US ETF
VEU
$66.1B
$256K 0.02%
5,374
+9
+0.2% +$403
AZN icon
215
AstraZeneca
AZN
$262B
$255K 0.02%
2,410
-12
-0.5% -$1.24K
CARR icon
216
Carrier Global
CARR
$51.3B
$250K 0.02%
+11,236
New +$209K
WSM icon
217
Williams-Sonoma
WSM
$27.2B
$250K 0.02%
+6,090
New +$207K
WU icon
218
Western Union
WU
$2.09B
$247K 0.02%
11,411
-2,000
-15% -$40.6K
PYPL icon
219
PayPal
PYPL
$48.7B
$245K 0.02%
+1,410
New +$195K
YUM icon
220
Yum! Brands
YUM
$42.4B
$243K 0.02%
+2,798
New +$239K
IMMU
221
DELISTED
Immunomedics Inc
IMMU
$240K 0.02%
+6,760
New +$198K
TRV icon
222
Travelers Companies
TRV
$78.7B
$239K 0.02%
2,097
LUMN icon
223
Lumen
LUMN
$6.61B
$236K 0.02%
23,549
+70
+0.3% +$700
PFG icon
224
Principal Financial Group
PFG
$24.1B
$235K 0.02%
+5,651
New +$206K
ITOT icon
225
iShares Core S&P Total US Stock Market ETF
ITOT
$93.3B
$234K 0.02%
+3,374
New +$221K

Similar funds

Grimes & Company's Q2 2020 Portfolio in Review

As of Q2 2020, Grimes & Company held 267 positions worth $1.44B, up 31% from $1.1B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Grimes & Company deployed $171M of net new capital in Q2 2020, opening 32 new positions and adding to 87 existing holdings. Its largest new stake was First Trust Preferred Securities and Income ETF: 3,607,715 shares worth $66.5M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was iShares 0-1 Year Treasury Bond ETF, an estimated $144M trimmed.

  • Grimes & Company's largest Q2 2020 buy was First Trust Preferred Securities and Income ETF: 3,607,715 shares worth $66.5M.
  • Grimes & Company added most to iShares Core S&P Small-Cap ETF in Q2 2020, an estimated $55.9M increase.
  • Grimes & Company's biggest Q2 2020 reduction was iShares 0-1 Year Treasury Bond ETF, cutting an estimated $144M.
  • Grimes & Company fully exited VanEck High Yield Muni ETF in Q2 2020, selling an estimated $12.4M.
  • Grimes & Company's ten largest holdings make up 38% of its $1.44B portfolio in Q2 2020.
  • Grimes & Company opened 32 new positions and closed 18 in Q2 2020.
  • Grimes & Company's portfolio value rose 31% quarter-over-quarter to $1.44B.

Based on Grimes & Company's 13F filing for Q2 2020, filed 31 Jul 2020.